SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-042672
Filing Date
2018-02-13
Accepted
2018-02-13 16:36:05
Documents
3
Group Members
CHRISTY SHAFFERCLAY B. THORPDOUGLAS REEDHATTERAS NC FUND, LPHATTERAS VENTURE ADVISORS IV SBIC, LLCHATTERAS VENTURE ADVISORS IV, LLCHATTERAS VENTURE ADVISORS V, LLCHATTERAS VENTURE PARTNERS IV, LPHATTERAS VENTURE PARTNERS V, L.P.JOHN C. CRUMPLERKENNETH B.

Document Format Files

Seq Description Document Type Size
1 SC 13G d539328dsc13g.htm SC 13G 197829
2 EX-99.A d539328dex99a.htm EX-99.A 16655
3 EX-99.B d539328dex99b.htm EX-99.B 19967
  Complete submission text file 0001193125-18-042672.txt   236584
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90214 | Film No.: 18604001
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701
Business Address 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701 919-484-0730
Hatteras Venture Partners IV SBIC, LP (Filed by) CIK: 0001675232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G